Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1977 2
1981 1
1982 2
1985 2
1987 5
1988 4
1989 5
1990 7
1991 4
1992 11
1993 6
1994 6
1995 3
1996 9
1997 5
1998 5
1999 2
2000 5
2001 7
2002 8
2003 2
2004 7
2005 6
2006 4
2007 7
2008 5
2009 8
2010 9
2011 6
2012 5
2013 7
2014 7
2015 4
2016 5
2017 16
2018 17
2019 16
2020 13
2021 8
2022 11
Text availability
Article attribute
Article type
Publication date

Search Results

250 results
Results by year
Filters applied: . Clear all
Page 1
Edoxaban for the Treatment of Cancer-Associated Venous Thromboembolism.
Raskob GE, van Es N, Verhamme P, Carrier M, Di Nisio M, Garcia D, Grosso MA, Kakkar AK, Kovacs MJ, Mercuri MF, Meyer G, Segers A, Shi M, Wang TF, Yeo E, Zhang G, Zwicker JI, Weitz JI, Büller HR; Hokusai VTE Cancer Investigators. Raskob GE, et al. N Engl J Med. 2018 Feb 15;378(7):615-624. doi: 10.1056/NEJMoa1711948. Epub 2017 Dec 12. N Engl J Med. 2018. PMID: 29231094 Free article. Clinical Trial.
Rivaroxaban for Thromboprophylaxis in High-Risk Ambulatory Patients with Cancer.
Khorana AA, Soff GA, Kakkar AK, Vadhan-Raj S, Riess H, Wun T, Streiff MB, Garcia DA, Liebman HA, Belani CP, O'Reilly EM, Patel JN, Yimer HA, Wildgoose P, Burton P, Vijapurkar U, Kaul S, Eikelboom J, McBane R, Bauer KA, Kuderer NM, Lyman GH; CASSINI Investigators. Khorana AA, et al. Among authors: wun t. N Engl J Med. 2019 Feb 21;380(8):720-728. doi: 10.1056/NEJMoa1814630. N Engl J Med. 2019. PMID: 30786186 Clinical Trial.
Rivaroxaban for thromboprophylaxis in acutely ill medical patients.
Cohen AT, Spiro TE, Büller HR, Haskell L, Hu D, Hull R, Mebazaa A, Merli G, Schellong S, Spyropoulos AC, Tapson V; MAGELLAN Investigators. Cohen AT, et al. N Engl J Med. 2013 Feb 7;368(6):513-23. doi: 10.1056/NEJMoa1111096. N Engl J Med. 2013. PMID: 23388003 Free article. Clinical Trial.
American Society of Hematology 2019 guidelines for sickle cell disease: cardiopulmonary and kidney disease.
Liem RI, Lanzkron S, D Coates T, DeCastro L, Desai AA, Ataga KI, Cohen RT, Haynes J, Osunkwo I, Lebensburger JD, Lash JP, Wun T, Verhovsek M, Ontala E, Blaylark R, Alahdab F, Katabi A, Mustafa RA. Liem RI, et al. Among authors: wun t. Blood Adv. 2019 Dec 10;3(23):3867-3897. doi: 10.1182/bloodadvances.2019000916. Blood Adv. 2019. PMID: 31794601 Free PMC article.
Sickle cell disease: an inherited thrombophilia.
Wun T, Brunson A. Wun T, et al. Hematology Am Soc Hematol Educ Program. 2016 Dec 2;2016(1):640-647. doi: 10.1182/asheducation-2016.1.640. Hematology Am Soc Hematol Educ Program. 2016. PMID: 27913540 Free PMC article. Review.
Biomolecular markers of cancer-associated thromboembolism.
Hanna DL, White RH, Wun T. Hanna DL, et al. Among authors: wun t. Crit Rev Oncol Hematol. 2013 Oct;88(1):19-29. doi: 10.1016/j.critrevonc.2013.02.008. Epub 2013 Mar 21. Crit Rev Oncol Hematol. 2013. PMID: 23522921 Free PMC article. Review.
Biomarkers of Cancer-Associated Thromboembolism.
Mahajan A, Wun T. Mahajan A, et al. Among authors: wun t. Cancer Treat Res. 2019;179:69-85. doi: 10.1007/978-3-030-20315-3_5. Cancer Treat Res. 2019. PMID: 31317481
Epidemiology of cancer-related venous thromboembolism.
Wun T, White RH. Wun T, et al. Best Pract Res Clin Haematol. 2009 Mar;22(1):9-23. doi: 10.1016/j.beha.2008.12.001. Best Pract Res Clin Haematol. 2009. PMID: 19285269 Free PMC article. Review.
250 results